Form 8-K RAPT Therapeutics, Inc. For: Jan 03
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
RAPT Therapeutics (RAPT) Announces Resignation of William Rieflin from Board
January 6, 2025 4:38 PM ESTOn January 3, 2025, William Rieflin resigned from the Board of Directors (the Board) of RAPT Therapeutics (NASDAQ: RAPT), effective immediately. Mr. Rieflins departure from the Board is not the result of any disagreement with the Company on any matter relating to the Companys operations,... More
